Table 1.
Gene | Description |
Fold Reduction in HC11-∆SAP vs. HC11-FL cells |
Functions | ||
---|---|---|---|---|---|
Microarrays in 0.03% FCS | qRT-PCR in 0.03% FCS | qRT-PCR in 3% FCS | |||
SRF-independent genes | |||||
Tnc |
Tenascin C, ECM protein |
3.07*** |
3.50*** |
26.34*** |
Cell adhesion, cell migration, wound healing and tissue remodeling, cancer cell invasion and metastasis [10] |
Anln |
Anillin, actin binding protein |
3.10*** |
1.93*** |
1.38** |
Cell cycle regulation [26], cell motility and cancer progression [26-28] |
Nox4 |
NADPH oxidase 4 |
3.31*** |
94.19** |
332.70*** |
Cell growth, differentiation and migration [29], tumor angiogenesis [30] |
Adamts16 |
Metallopeptidase, ECM protein |
3.63*** |
5.70*** |
14.84** |
Cell growth and motility [31], role in arthritis [32] and cancer [31] |
Krt5 |
Keratin 5, intermediate filament protein |
3.73*** |
2.74*** |
8.02*** |
Protein synthesis, epithelial cell growth and differentiation [33,34] |
p15 (PAF) |
2810417H13Rik, PCNA-associated factor |
3.91*** |
1.89*** |
1.34*** |
DNA repair and cell cycle regulation, cell survival and proliferation, tumorigenesis [35-37], hematopoiesis [38] |
Ass1 |
Argininosuccinate synthetase 1 |
4.23*** |
3.89** |
2.72** |
Regulation of nitric oxide production and cell viability [39,40] |
Cd34 |
CD34 antigen, stem cell antigen |
4.25*** |
10.61*** |
1.72*** |
Vessel development and function [41], tumor growth [42,43] |
Wisp1 |
WNT1 inducible signaling pathway protein 1, ECM protein |
4.41*** |
2.54** |
4.06** |
Cell proliferation and survival, ECM deposition and turnover, EMT, tumorigenesis, tissue remodeling [44] |
Mcm6 |
Minichromosome maintenance complex component 6 |
4.42*** |
2.83*** |
1.30*** |
Cell cycle regulation [45] |
Car12 |
Carbonic anyhydrase 12 |
4.58*** |
16.11*** |
26.07** |
Cell survival under hypoxic conditions, tumor-associated cell migration and invasion [46,47] |
Htatip2 |
Hyaluronectin, TIP30, transcriptional regulator |
5.89*** |
548.59*** |
245.27*** |
Regulation of apoptosis [48], tumor growth and metastasis [49] |
Kif26b |
Kinesin family member 26B |
6.33*** |
8.36*** |
61.22*** |
Regulation of adhesion and cell polarity in kidney development [50] |
SRF-dependent genes | |||||
Lox |
Lysyl oxidase, ECM protein |
4.61*** |
4.70** |
12.04*** |
ECM turnover, connective tissue remodeling and repair, tumor progression and metastasis [51,52] |
Mmp12 |
Matrix metallopeptidase 12, metalloelastase |
12.01*** |
23.49*** |
4.90** |
ECM degradation in tissue remodeling [49] and tumorigenesis [53] |
Mmp3 | Matrix metallopeptidase 3, stromelysin-1 | 15.64*** | 14.70*** | 2.08** | ECM degradation in tissue remodeling [49] and tumorigenesis [54] |
Abbreviations: ECM extracellular matrix protein, PCNA proliferating cell nuclear antigen, EMT epithelial-to-mesenchymal transition.
***P < 0.001, **P < 0.01, Student’s t test.